French pipeline coating service provider EUPEC (EUPX.US) is sprinting towards a US IPO, with the fundraising amount increasing by 200% to $15 million.
French land and sea steel pipe coating solutions provider EUPEC International Group (EUPX.US) updated its plan for an IPO in the United States on Monday, significantly increasing the planned fundraising amount.
It is reported that EUPEC International Group (EUPX.US), a provider of steel pipeline coating solutions in France, updated its IPO plan to the United States on Monday, significantly increasing the planned fundraising scale. The company, headquartered in Grand-Saunt, France, currently plans to issue 3.8 million shares at a price of $4 per share, raising $15 million. Previously submitted documents showed that the company had originally planned to issue 1.3 million shares at the same price. Based on the revised trading scale, EUPEC's fundraising amount will increase by 200% compared to the original expectations, and the company's market value is expected to reach $95 million.
EUPEC focuses on providing special coating services for onshore and offshore steel pipelines in the water, oil, and natural gas industries, with services including pipeline coating, custom coating, field joint coating, and coil-to-coil solutions. The company operates a 15-hectare factory in Dunkirk and has two additional facilities in France, and has provided project support for energy giants such as TotalEnergies, Eni, Exxon Mobil Corporation, Petrobras, Shell, BP, and many large engineering contractors.
Founded in 2022, EUPEC achieved revenue of $9 million in the 12 months ending June 30, 2025. The company plans to list on the NASDAQ under the stock symbol "EUPX", with R.F. Lafferty & Co. serving as the exclusive bookrunner for the offering.
Related Articles

On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.
.png)
New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.

New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
.png)





